Correction to Kasibhatla et al. How Much Radiation Is the Chemotherapy Worth in Advanced Head and Neck Cancer? (Int J Radiat Oncol Biol Phys 2007;68:1491-1495)

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 2, 2008, Pages 326-329

  Fowler, Jack F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chemoradiotherapy; Head and neck; Modeling; Radiation equivalent

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; EDITORIAL; HEAD AND NECK CANCER; HUMAN; MEDICAL ERROR; PRIORITY JOURNAL; RADIATION DOSE;

ALGORITHMS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEAD AND NECK NEOPLASMS; HUMANS; RELATIVE BIOLOGICAL EFFECTIVENESS; RESEARCH DESIGN; TIME FACTORS;

EID: 43049170019     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.01.052     Document Type: Editorial

References (17)

1. Kasibhatla M., Kirkpatrick J.P., and Brizel D.M. How much radiation is the chemotherapy worth in advanced head and neck cancer?. Int J Radiat Oncol Biol Phys 68 (2007) 1491-1495
2. Jones B., and Sanghera P. Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma. Int J Radiat Oncol Biol Phys 68 (2007) 441-448
3. Dörr W., Hamilton C.S., Boyd T., et al. Radiation-induced changes in cellularity and proliferation in human oral mucosa. Int J Radiat Oncol Biol Phys 52 (2002) 911-917
4. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62 (1989) 679-694
5. Withers H.R., Taylor J.M.G., and Maciejewsski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27 (1988) 131-146
6. Bentzen S., and Bauman M. The linear quadratic model in clinical practice. In: Steel G.G. (Ed). Basic clinical radiobiology. 3rd ed. (2002), Arnold, London 138
7. Brenner J.D. Accelerated repopulation during radiotherapy. Quantitative evidence for delayed onset. Radiat Oncol Invest 1 (1993) 167-172
8. Hendry J.H., Roberts S.A., Slevin N.J., et al. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiother Oncol 31 (1994) 14-22
9. Roberts S.A., and Hendry J.H. Time factors in larynx tumour radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers. Int J Radiat Oncol Biol Phys 45 (1999) 1247-1257
10. Toma-Dasu I., Dasu A., Denekamp J., et al. Comments on the "standard effective doses" for proliferative tumours. Phys Med Biol 45 (2000) L45-L50
11. Hall E.J. Radiobiology for the radiologist. 4th ed. (1994), J.B. Lippincott, Philadelphia p. 226
12. Fowler J.F. Practical time-dose evaluation, or how to stop worrying and love LQ. In: Levitt S.H., Purdy J.A., Perez C.A., et al. (Eds). Technical basis of radiation therapy. 4th revised ed. (2006), Springer-Verlag, Heidelberg 3-31
13. Fowler J.F. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling. Clin Oncol (R Coll Radiol) 19 (2007) 8-22
14. Okunieff P., Morgan D., Niemierko A., et al. Radiation dose response of human tumors. Int J Radiat Oncol Biol Phys 32 (1995) 1227-1237
15. Thames H.D., Schultheiss T.E., Hendry J.H., et al. Can modest escalations of dose be detected as increased tumor control?. Int J Radiat Oncol Biol Phys 22 (1992) 241-246
16. Overgaard J., Hansen H.S., Lena S., et al. Five compared with 6 fractions per week of conventional radiotherapy of squamous cell carcinoma of the head and neck: DAHANCA 6 & 7. Lancet 362 (2003) 933-940
17. Noether G. Introduction to statistics: a fresh approach (1971), Houghton Mifflin, Boston p. 226